'Going wild' in the dawn of a new health care administration

How will Trump's election change the FDA? History isn't likely to repeat itself, but it will rhyme.

November 9, 2024 Check out STAT+

Sponsored By

This week from STAT's executive editor: "We are at a unique moment in our country's history, when an understanding of the issues that STAT covers is more relevant than ever before — to both our personal lives and our professional lives. We are not a partisan news organization. But we believe in science, accountability, and the pursuit of truth." Read Rick's full letter here, and take care this weekend.

Alex Wong/Getty Images What letting RFK Jr. 'go wild' might mean for Trump's FDA Kennedy has been the Trump campaign's primary mouthpiece on the FDA and other health policy issues. While experts have found a silver lining in Kennedy's focus on improving food regulation, they worry that his distrust of vaccines and FDA civil servants will wreak havoc and delay patient access to critical medicine. Read more. By Lizzy Lawrence

---

---

Christine Kao/STAT; Photos: Getty 'MAHA' is moving into Trump's White House. Here's who RFK Jr. could bring along for the ride  The sweeping election victory for President-elect Donald Trump also marks the start of an ambitious anti-chronic disease campaign, "Make America Healthy Again," led by lawyer, environmentalist, and anti-vaccine advocate Robert F. Kennedy Jr. A rotating cast of characters — old and new; influencers, entrepreneurs, and lawmakers — has been amplifying Kennedy's arguments, and are now poised to become even more influential as Trump assembles his second administration. Read more. By Isabella Cueto Photo illustration: Anna Yeo/STAT; Photos: Getty Six GOP lawmakers poised for power on health care as the Senate flips Republican The Senate has been under Democratic control for the past four years, so newly empowered Republican committee chairs will have a bigger platform to advance their policy initiatives. Read more. By Megan Molteni In case you missed it... Trump promised public health system upheaval. What comes next? Health and science experts on their hopes and worries for the Trump era. Trump's return raises concerns about funding cuts and politicization at the NIH. Hours after Trump's election victory, NIH director Monica Bertagnolli rushed to reassure the agency's 20,000-plus workforce. How will Trump's election change the FDA? History isn't likely to repeat itself, but it will rhyme. Medicaid could be targeted for spending cuts under Trump. The threat to the program emerges, in part, from simple math. Ahead of Trump's presidency, biotech and pharmaceutical leaders are preparing for the shift to an administration with a complicated history. The probe of AstraZeneca executive Leon Wang in China raises questions about company's tactics.

---

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser